HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 3

ARCTIC-INTERRUPTION: 1 years versus 2 years of double anti-platelet

This study randomized 1259 patients to receive one year versus 2 years of double anti anti-platelet after...
solaci -
Learn More
Day 1

SORT OUT VI: Biolimus eluting stent versus zotarolimus-eluting stent; similar results

Few studies have compared head to head the 2nd generation drug eluting stents. This study randomized 1:1...
solaci -
Learn More
Day 1

COREVALVE EXTREME RISK: Promising results with CoreValve in very high-risk patients

Percutaneous aortic valve implantation ( TAVI ) recently demonstrated its superiority over medical treatment in patients with...
solaci -
Learn More
Day 1

SAFE-PCI for Women: Radial versus femoral access for women

Radial access is associated with a lower rate of vascular and bleeding complications however female patients with...
solaci -
Learn More
Day 2

TRYTON: Stent dedicated to bifurcations fails to demonstrate non-inferiority when compared with provisional

The aim of this study was to compare the results of stent TRYTON (non-drug eluting) in the...
solaci -
Learn More
Day 2

NORDIC-BALTIC IV: 2 stents versus provisional stent in bifurcations

This study aimed to compare the strategy of 2 stents versus provisional stenting in true bifurcations.It was...
solaci -
Learn More
Day 2

EUROMAX: Early and prolonged infusion of bivalirudin reduces mortality in AMI

Bivalirudin reduced mortality and bleeding compared to heparin and glycoprotein IIbIIIa in HORIZONS- AMI study. However there...
solaci -
Learn More
Day 1

INTIME: Home monitoring of severe heart failure patients gives promising results.

Rehospitalization or death due to worsening heart failure is often preceded by changes in clinical parameters, weight...
solaci -
Learn More